艾塞那肽注射引起的富含嗜酸性粒细胞的肉芽肿性脂膜炎。 - Suppr

Suppr

超能文献

Eosinophil-rich granulomatous panniculitis caused by exenatide injection.

作者信息

Boysen Nicholas C, Stone Mary Seabury

机构信息

Department of Dermatology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.

出版信息

J Cutan Pathol. 2014 Jan;41(1):63-5. doi: 10.1111/cup.12246. Epub 2013 Nov 14.

DOI:10.1111/cup.12246

PMID:24224897

Abstract

摘要

相似文献

Eosinophil-rich granulomatous panniculitis caused by exenatide injection.

J Cutan Pathol. 2014 Jan;41(1):63-5. doi: 10.1111/cup.12246. Epub 2013 Nov 14.

Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site.

Am J Dermatopathol. 2014 Jun;36(6):510-2. doi: 10.1097/DAD.0000000000000036.

Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series.

Am J Gastroenterol. 2010 Dec;105(12):2707-9. doi: 10.1038/ajg.2010.363.

Exenatide (Byetta) for type 2 diabetes.

Med Lett Drugs Ther. 2005 Jun 6;47(1210):45-6.

Once-weekly exenatide: an extended-duration glucagon-like peptide agonist for the treatment of type 2 diabetes mellitus.

Pharmacotherapy. 2013 Jun;33(6):627-38. doi: 10.1002/phar.1240. Epub 2013 Apr 1.

Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.

Pharmacotherapy. 2007 Oct;27(10):1449-55. doi: 10.1592/phco.27.10.1449.

Extended-release exenatide (Bydureon) for type 2 diabetes.

Med Lett Drugs Ther. 2012 Mar 19;54(1386):21-3.

Molecule of the month. Exenatide.

Drug News Perspect. 2003 Nov;16(9):621.

Exenatide: pancreatitis. Watch out for nausea and vomiting.

Prescrire Int. 2008 Jun;17(95):112.

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.

Diabet Med. 2006 Mar;23(3):240-5. doi: 10.1111/j.1464-5491.2006.01800.x.

引用本文的文献

Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons.

Dermatol Ther (Heidelb). 2025 Sep 9. doi: 10.1007/s13555-025-01537-5.

A Review of Glucagon-like Peptide-1 in Dermatology.

J Clin Aesthet Dermatol. 2025 Mar;18(3):42-50.

Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature.

Arch Dermatol Res. 2024 May 25;316(6):248. doi: 10.1007/s00403-024-02969-3.

Clin Rheumatol. 2023 Sep;42(9):2501-2506. doi: 10.1007/s10067-023-06612-w. Epub 2023 May 18.

Eosinophilic Panniculitis Following the Subcutaneous Injection of Exenatide Extended-Release.

Ann Dermatol. 2020 Jun;32(3):230-232. doi: 10.5021/ad.2020.32.3.230. Epub 2020 Apr 24.

Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS.

J Pharm Anal. 2020 Jun;10(3):233-239. doi: 10.1016/j.jpha.2020.02.008. Epub 2020 Feb 22.

HYPOTHYROIDISM COULD BE A POTENTIAL FACTOR TO PROLONG SUBCUTANEOUS NODULES OF EXENATIDE ONCE WEEKLY: A CASE REPORT.

AACE Clin Case Rep. 2019 Apr 25;5(3):e197-e200. doi: 10.4158/ACCR-2018-0418. eCollection 2019 May-Jun.

Persistent injection site nodules from exenatide: Successful treatment with intralesional triamcinolone.

JAAD Case Rep. 2018 Sep 18;4(8):830-832. doi: 10.1016/j.jdcr.2018.06.009. eCollection 2018 Sep.

Diabetes mellitus and the skin.

Rev Endocr Metab Disord. 2016 Sep;17(3):269-282. doi: 10.1007/s11154-016-9373-0.

Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.

J Vet Intern Med. 2016 Jan-Feb;30(1):92-100. doi: 10.1111/jvim.13817. Epub 2015 Dec 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验